<html><head><title>Last Compo BVF INC/IL</title></head><link rel="stylesheet" type="text/css" href="alphaleague_style.css"/>
                  <body><h2>BVF INC/IL<br>#assets : 62<br>AUMs(M$) : 1,836</h2><table border="1" class="dataframe mystyle">
  <thead>
    <tr style="text-align: center;">
      <th></th>
      <th>name</th>
      <th>rpt_dt</th>
      <th>w</th>
      <th>name_prev</th>
      <th>rpt_dt_prev</th>
      <th>w_prev</th>
      <th>dw</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>75943R102</th>
      <td>RELAY THERAPEUTICS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">7.8</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">7.8</div></td>
    </tr>
    <tr>
      <th>85205L107</th>
      <td>SPRINGWORKS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>5.3</td>
      <td>SPRINGWORKS THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>5.9</td>
      <td>-0.6</td>
    </tr>
    <tr>
      <th>760273102</th>
      <td>REPARE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>5.1</td>
      <td>REPARE THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>3.7</td>
      <td>1.4</td>
    </tr>
    <tr>
      <th>501575104</th>
      <td>KYMERA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">4.6</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">4.6</div></td>
    </tr>
    <tr>
      <th>98401F105</th>
      <td>XENCOR INC</td>
      <td>30September20</td>
      <td>4.3</td>
      <td>XENCOR INC</td>
      <td>30June20</td>
      <td>4.1</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>98419J206</th>
      <td>XOMA CORP DEL</td>
      <td>30September20</td>
      <td>4.2</td>
      <td>XOMA CORP DEL</td>
      <td>30June20</td>
      <td>4.9</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>23282W605</th>
      <td>CYTOKINETICS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">3.9</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">3.9</div></td>
    </tr>
    <tr>
      <th>76155X100</th>
      <td>REVOLUTION MEDICINES INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">3.9</div></td>
      <td>REVOLUTION MEDICINES INC</td>
      <td>30June20</td>
      <td>1.5</td>
      <td><div p style="color:black;background:#dbfad2;">2.4</div></td>
    </tr>
    <tr>
      <th>N5749R100</th>
      <td>MERUS N V</td>
      <td>30September20</td>
      <td>3.6</td>
      <td>MERUS N V</td>
      <td>30June20</td>
      <td>5.0</td>
      <td>-1.4</td>
    </tr>
    <tr>
      <th>H00263105</th>
      <td>AC IMMUNE SA</td>
      <td>30September20</td>
      <td>2.6</td>
      <td>AC IMMUNE SA</td>
      <td>30June20</td>
      <td>4.6</td>
      <td>-2.0</td>
    </tr>
    <tr>
      <th>74366E102</th>
      <td>PROTAGONIST THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>2.5</td>
      <td>PROTAGONIST THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>2.5</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>50127T109</th>
      <td>KURA ONCOLOGY INC</td>
      <td>30September20</td>
      <td>2.4</td>
      <td>KURA ONCOLOGY INC</td>
      <td>30June20</td>
      <td>2.7</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>04016X101</th>
      <td>ARGENX SE</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#f5d2ce;">2.4</div></td>
      <td>ARGENX SE</td>
      <td>30June20</td>
      <td>5.4</td>
      <td><div p style="color:black;background:#f5d2ce;">-3.0</div></td>
    </tr>
    <tr>
      <th>03969F109</th>
      <td>ARCUS BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>2.4</td>
      <td>ARCUS BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>2.8</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>15117B202</th>
      <td>CELLDEX THERAPEUTICS INC NEW</td>
      <td>30September20</td>
      <td>2.4</td>
      <td>CELLDEX THERAPEUTICS INC NEW</td>
      <td>30June20</td>
      <td>2.1</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>45258J102</th>
      <td>IMMUNOVANT INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td>IMMUNOVANT INC</td>
      <td>30June20</td>
      <td>1.6</td>
      <td>0.6</td>
    </tr>
    <tr>
      <th>45166A102</th>
      <td>IDEAYA BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td>IDEAYA BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>2.8</td>
      <td>-0.6</td>
    </tr>
    <tr>
      <th>76029N106</th>
      <td>REPLIMUNE GROUP INC</td>
      <td>30September20</td>
      <td>2.1</td>
      <td>REPLIMUNE GROUP INC</td>
      <td>30June20</td>
      <td>3.5</td>
      <td>-1.4</td>
    </tr>
    <tr>
      <th>98420N105</th>
      <td>XENON PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>2.1</td>
      <td>XENON PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>2.7</td>
      <td>-0.6</td>
    </tr>
    <tr>
      <th>33830X104</th>
      <td>FIVE PRIME THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>2.0</td>
      <td>FIVE PRIME THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>3.0</td>
      <td>-1.0</td>
    </tr>
    <tr>
      <th>34962G109</th>
      <td>FORTE BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>2.0</td>
      <td>FORTE BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>0.8</td>
      <td>1.2</td>
    </tr>
    <tr>
      <th>87164F105</th>
      <td>SYNDAX PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>1.9</td>
      <td>SYNDAX PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>2.2</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>462222100</th>
      <td>IONIS PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#f5d2ce;">1.8</div></td>
      <td>IONIS PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>5.1</td>
      <td><div p style="color:black;background:#f5d2ce;">-3.3</div></td>
    </tr>
    <tr>
      <th>869367102</th>
      <td>SUTRO BIOPHARMA INC</td>
      <td>30September20</td>
      <td>1.6</td>
      <td>SUTRO BIOPHARMA INC</td>
      <td>30June20</td>
      <td>1.1</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>00166B105</th>
      <td>ALX ONCOLOGY HLDGS INC</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.3</td>
    </tr>
    <tr>
      <th>23284F105</th>
      <td>CYTOMX THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.2</td>
      <td>CYTOMX THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>1.6</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>608550109</th>
      <td>MOLECULAR TEMPLATES INC</td>
      <td>30September20</td>
      <td>1.2</td>
      <td>MOLECULAR TEMPLATES INC</td>
      <td>30June20</td>
      <td>1.8</td>
      <td>-0.6</td>
    </tr>
    <tr>
      <th>38000Q102</th>
      <td>GLYCOMIMETICS INC</td>
      <td>30September20</td>
      <td>1.2</td>
      <td>GLYCOMIMETICS INC</td>
      <td>30June20</td>
      <td>1.6</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>816212104</th>
      <td><div p style="background:#fcfa72;">SELECTA BIOSCIENCES INC</div></td>
      <td>30September20</td>
      <td>1.1</td>
      <td>SELECTA BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>1.4</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>690469101</th>
      <td>OVID THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>OVID THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>1.0</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>45665G303</th>
      <td>INFINITY PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>INFINITY PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.9</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>29668H708</th>
      <td>ESSA PHARMA INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>ESSA PHARMA INC</td>
      <td>30June20</td>
      <td>0.7</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>032724106</th>
      <td>ANAPTYSBIO INC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>ANAPTYSBIO INC</td>
      <td>30June20</td>
      <td>1.7</td>
      <td>-0.8</td>
    </tr>
    <tr>
      <th>13124Q106</th>
      <td>CALLIDITAS THERAPEUTICS AB</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>CALLIDITAS THERAPEUTICS AB</td>
      <td>30June20</td>
      <td>1.0</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>84833T103</th>
      <td>SPERO THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>SPERO THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>12648L601</th>
      <td>CTI BIOPHARMA CORP</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>CTI BIOPHARMA CORP</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>13089P101</th>
      <td>CALITHERA BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>CALITHERA BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>2.3</td>
      <td>-1.5</td>
    </tr>
    <tr>
      <th>88339T103</th>
      <td>THERAPEUTICS ACQUISITION COR</td>
      <td>30September20</td>
      <td>0.7</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.7</td>
    </tr>
    <tr>
      <th>92337C104</th>
      <td>VERASTEM INC</td>
      <td>30September20</td>
      <td>0.7</td>
      <td>VERASTEM INC</td>
      <td>30June20</td>
      <td>0.5</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>720795103</th>
      <td>PIERIS PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>PIERIS PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.5</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>71722W107</th>
      <td>PHATHOM PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>PHATHOM PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.6</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>55279B202</th>
      <td>MEI PHARMA INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>MEI PHARMA INC</td>
      <td>30June20</td>
      <td>1.0</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>171757107</th>
      <td>CIDARA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>CIDARA THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.8</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>372427401</th>
      <td>GENOCEA BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>GENOCEA BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>698102209</th>
      <td>PANACEA ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>M47364100</th>
      <td>GAMIDA CELL LTD</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>GAMIDA CELL LTD</td>
      <td>30June20</td>
      <td>0.6</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>05492W103</th>
      <td>BCTG ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>212326300</th>
      <td>CONTRAFECT CORP</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>CONTRAFECT CORP</td>
      <td>30June20</td>
      <td>0.6</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>M47238106</th>
      <td>GALMED PHARMACEUTICALS LTD</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>GALMED PHARMACEUTICALS LTD</td>
      <td>30June20</td>
      <td>0.5</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>221015100</th>
      <td>CORVUS PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>CORVUS PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>299734103</th>
      <td>EVELO BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>EVELO BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>0.3</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>98420X103</th>
      <td>X4 PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>X4 PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.5</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>29604W108</th>
      <td>ERYTECH PHARMA</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>ERYTECH PHARMA</td>
      <td>30June20</td>
      <td>0.3</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>231269200</th>
      <td>CURIS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>CURIS INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>34986J204</th>
      <td>FORWARD PHARMA A/S</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>FORWARD PHARMA A/S</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>023111206</th>
      <td>AMARIN CORP PLC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>867328874</th>
      <td>SUNESIS PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>09071M205</th>
      <td>BIOLINERX LTD</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>BIOLINERX LTD</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>67011N105</th>
      <td>NOVUS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>NOVUS THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>849431101</th>
      <td>SPRING BK PHARMACEUTICALS IN</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>SPRING BK PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>75915K200</th>
      <td>REGULUS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>REGULUS THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>30161Q104</th>
      <td>EXELIXIS INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>EXELIXIS INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>74257L108</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>PRINCIPIA BIOPHARMA INC</td>
      <td>30June20</td>
      <td>5.4</td>
      <td><div p style="color:black;background:#f5d2ce;">-5.4</div></td>
    </tr>
    <tr>
      <th>09203E105</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>BLACK DIAMOND THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.9</td>
      <td>-0.9</td>
    </tr>
    <tr>
      <th>86877M209</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>SURFACE ONCOLOGY INC</td>
      <td>30June20</td>
      <td>0.8</td>
      <td>-0.8</td>
    </tr>
    <tr>
      <th>867328700</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>SUNESIS PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
  </tbody>
</table></body></html>.